While direct P-gp inhibition has shown limited clinical success, alternative strategies, including the exploration of natural compounds, the repurposing of existing drugs, and the development of novel nanotechnological approaches, offer promising avenues to overcome drug resistance and improve treatment outcomes in several diseases, including cancer and immune disorders. The gene discussed is PGP; the disease is cancer.